USPTO 2015–2025 USPTO PatentsView US Corporation

Ventis Medical, Inc.

USPTO PatentsView assignee record - 9 granted patents across 2 technology areas, recorded in grant years 2023–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: G06Q (Information AND Communication Technology [ICT] Specially Adapted FOR Administrative, Commercial, Financial, Managerial OR Supervisory PURPOSES; Systems OR Methods Specially Adapted FOR Administrative,).

RSS updates for this company

The verdict

According to USPTO PatentsView, Ventis ranks #30,544 of 49,997 tracked US assignees by granted-patent volume, with 9 patents across 2 technology areas.

#30,544
of 49,997 US assignees by volume
Top 49%
by Innovation Score (35.7/100)
4.6
avg claims per patent

USPTO PatentsView assignee plate

Corpus R30544 · US Corporation #30,544 · 9 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-SPARSE · TYPE-USCORP · SPAN-YRS · BOOK-RICH

  • GRANTS-MICRO 9 grants
  • MID-PACK #30,544/49,997
  • PHOTO-FINISH Vecor IP Holdings
  • CPC-NARROW G06Q · 2 areas
  • INNOV-THIN 35.7/100
  • CLAIMS-SPARSE 4.6 claims/avg
  • TYPE-USCORP US Corporation
  • SPAN-YRS 2023–2025 · 3y
  • BOOK-RICH 9/10 fields

Nearest grant-volume peer: Vecor IP Holdings Limited (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Innovation-score neighbourhood around Ventis

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Ventis's Innovation Score is 35.7/100 (top 49% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Where Ventis's grants concentrate

Ventis Medical, Inc. is a focused PatentsView assignee: 2 CPC subclasses with 22.2% of grants classified under G06Q (Information AND Communication Technology [ICT] Specially Adapted FOR Administrative, Commercial, Financial, Managerial OR Supervisory PURPOSES; Systems OR Methods Specially Adapted FOR Administrative,). Peak complete grant year is 2024 (4 grants) versus a trough of 1 in 2023. By volume, Ventis sits between Vecor IP Holdings Limited and Vestaron Corporation.

Ventis's three-year grant acceleration

Ventis Medical, Inc. shows 5 grants in 2022–2024 against only 0 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at Ventis's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Ventis holds 9 patents at rank #30,529, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Ventis

By rank, the assignees closest to #30,529 in granted patent volume.

Leaders in G06Q (Information AND Communication Technology [ICT] Specially…)

Other assignees with the most granted patents in Ventis's primary technology class.

Ventis's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

36 Top 49% higher than 51% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

012345 202320242025 4
USPTO utility patent grants by year · 2023–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2023–2019 baseline. Full figures in the table below.

View data table
Ventis Medical, Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2023 1 11.1%
2024 4 44.4%
2025partial year 4 44.4%

Where it ranks

Overall rank by patents

#30,544

of 49,997 tracked assignees

Innovation Score

35.7 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Ventis Medical, Inc.'s patent record in context - here's where to go next.

  • Ventis Medical, Inc.'s lead technology class is G06Q (Information AND Communication Technology [ICT] Specially Adapted FOR Administrative, Commercial, Financial, Managerial OR Supervisory PURPOSES; Systems OR Methods Specially Adapted FOR Administrative,), 22.2% of its portfolio - see every assignee active in that class. Explore G06Q
  • Ranked #30,544 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Ventis Medical, Inc. against Vecor IP Holdings Limited, an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 35.7/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.